S100B Protein and Postoperative Cognitive Dysfunction
S100B Protein as Predictor of Cognitive Dysfunction After Robot-assisted Radical Prostatectomy: A Prospective Observational Study
1 other identifier
observational
89
1 country
1
Brief Summary
Primary aim of this study is to evaluate the association between postoperative cognitive dysfunction and increased serum levels of S100B protein after robot-assisted laparoscopic radical prostatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2017
CompletedFirst Posted
Study publicly available on registry
January 12, 2017
CompletedStudy Start
First participant enrolled
February 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2018
CompletedMay 31, 2018
May 1, 2018
9 months
January 9, 2017
May 30, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Score in Neuropsychological Tests
This assessment will be applied before surgery, and 7 days and 3 months after surgery.
Change from neuropsychological test scores at 3 months.
Interventions
Neuropsychological tests of all patients will conduct on the one day prior to surgery, the 7th day after surgery, and the 3rd month after surgery
Eligibility Criteria
Adults between 50 and 90 years of age with robot assisted laparoscopic radical prostatectomy , were selected in the study.
You may qualify if:
- over 50 years old
- scheduled for robotic-assisted laparoscopic radical prostatectomy
- the body mass index ranged from 18 kg/m2 to 25 kg/m2
- American Society of Anesthesiologists class I, II or III
You may not qualify if:
- Patients with previous neurological deficit (symptomatic stroke, hemorrhage, transient ischemic attack)
- other neurologic disorders (epilepsy, trauma, intra- or extracranial malignancy)
- psychiatric diseases (schizophrenia, or depressive disorder)
- alcoholism or any other drug dependence
- serious hearing or visual impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation
Antalya, 07100, Turkey (Türkiye)
Related Publications (5)
Silva FP, Schmidt AP, Valentin LS, Pinto KO, Zeferino SP, Oses JP, Wiener CD, Otsuki DA, Tort AB, Portela LV, Souza DO, Auler JO Jr, Carmona MJ. S100B protein and neuron-specific enolase as predictors of cognitive dysfunction after coronary artery bypass graft surgery: A prospective observational study. Eur J Anaesthesiol. 2016 Sep;33(9):681-9. doi: 10.1097/EJA.0000000000000450.
PMID: 27433840BACKGROUNDTomaszewski D. Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An Update. Biomed Res Int. 2015;2015:402959. doi: 10.1155/2015/402959. Epub 2015 Aug 31.
PMID: 26417595BACKGROUNDChen K, Wei P, Zheng Q, Zhou J, Li J. Neuroprotective effects of intravenous lidocaine on early postoperative cognitive dysfunction in elderly patients following spine surgery. Med Sci Monit. 2015 May 15;21:1402-7. doi: 10.12659/MSM.894384.
PMID: 25975969BACKGROUNDvan Munster BC, Korevaar JC, Korse CM, Bonfrer JM, Zwinderman AH, de Rooij SE. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry. 2010 Mar;25(3):234-9. doi: 10.1002/gps.2326.
PMID: 19575407BACKGROUNDKavrut Ozturk N, Kavakli AS, Arslan U, Aykal G, Savas M. [S100B level and cognitive dysfunction after robotic-assisted laparoscopic radical prostatectomy procedures: a prospective observational study]. Braz J Anesthesiol. 2020 Nov-Dec;70(6):573-582. doi: 10.1016/j.bjan.2020.06.006. Epub 2020 Oct 15.
PMID: 33213866DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nilgun Kavrut Ozturk, M.D.
Antalya Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2017
First Posted
January 12, 2017
Study Start
February 14, 2017
Primary Completion
November 24, 2017
Study Completion
February 14, 2018
Last Updated
May 31, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share